Drug
TD 4208
TD 4208: highest development phase Phase 3, developed by Viatris. 4 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Viatris
Trials
| Drug | Phase | Indication |
|---|---|---|
| TD-4208 NCT02518139 | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) |
| TD-4208 NCT02109172 | Phase 2 | Chronic Obstructive Pulmonary Disease |
| TD-4208 NCT02040792 | Phase 2 | COPD |
| TD-4208 NCT02581592 | Phase 1 | Hepatic Impairment |
Latest
No recent events.
Follow TD 4208 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.